Mode
Text Size
Log in / Sign up
Phase 3 N=135 Single-blind Prevention

Residual Effect of Chlorhexidine-alcohol Compared to Triclosan-alcohol

Infectious Diseases

Enrolled (actual)
135
Serious AEs
Results posted
Jul 2014
Primary outcome: Primary: Evaluate the Residual Effect of Chlorhexidine 2% / Isopropyl Alcohol 70% Administered Topically — 24; 48; 24 (CFU/cm2) — p=<0.05

Study Design & Population

Study type
Interventional
Phase
Phase 3
Interventions
Bacterial culture of the prepared skin's areas with two antiseptics and two controls (Other); Preparing skin's areas to be tested with two antiseptics and two controls (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Universidad de Guanajuato
Primary completion
Apr 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
Evaluate the Residual Effect of Chlorhexidine 2% / Isopropyl Alcohol 70% Administered Topically
24; 48; 24 <0.05 sig
PRIMARY
Evaluate the Residual Effect of Triclosan 1% / Isopropyl Alcohol 70% Administered Topically.
48; 48; 96 <0.05 sig
PRIMARY
Evaluate the Effect on the Skin Flora Application Process of Antiseptics by Sterile Swab
480; 216; 288; 96; 288; 96 <0.05 sig
SECONDARY
Detect Presence of Allergy or Skin Reaction by the Antiseptic Application

Summary

Currently there are few options for skin antisepsis, commercially antiseptic triclosan is mainly used. To have more options, this study is necessary, where investigators will determine the residual effect of 2% chlorhexidine in 70% isopropyl alcohol and 1% triclosan in 70% isopropyl alcohol and choose the one with the best characteristics for skin antisepsis.

Eligibility Criteria

Inclusion Criteria

  • Healthy adult volunteers
  • Volunteers who have completed the stabilization phase of skin flora.
  • Volunteers who does not taken a shower or bath 24 hours before the test.

Exclusion Criteria

  • Volunteers with a score below 100 Colony Forming Unit per square centimeter (CFU/cm2) of forearm skin surface in the control after the stabilization of the skin flora.
  • History of skin allergies or atopy, as well as reactions to alcohol, soaps, iodine, chlorine or latex.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01762904). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search